பிரதான பலகை பட்டியல் விதிகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from பிரதான பலகை பட்டியல் விதிகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In பிரதான பலகை பட்டியல் விதிகள் Today - Breaking & Trending Today

China Resources Power : Sustainable Development Report 2020


To the Board of Directors of China Resources Power Holdings Company Limited
We have been engaged by the Board of Directors of China Resources Power Holdings Company Limited (the Company ) to perform a limited assurance engagement in relation to the selected data listed below and identified
with an asterisk [ ] on page 77 to 79 (the Selected Sustainability Information ) in the Company s Sustainability Report for the year ended 31 December 2020 (the 2020 Sustainability Report ).
Selected Sustainability Information
Selected Sustainability Information#
Nitrogen Oxides (NOx) emissions rate (g/kWh)
Sulphur Dioxide (SO2) emissions (kt)
Sulphur Dioxide (SO2) emission rate (g/kWh)
Particulates emissions (kt)
Installation rate of desulfurization device in coal-fired thermal power plants (%) ....

Gao Fang , Nei Mongol , Lang Yan , Min Qing , Xiao Lei , Zhou Lei , Wan Chai , Hong Kong General , Hong Kong , France General , Tang Yong , Long Qing , Lin Ying , Wu Gang , Sui Xi , Wang Yan , Tibet Autonomous Region , Inner Mongolia , Bi Yang , Jing Wei , United Kingdom , Wang Shiwan , Yangtze River , China General , Inner Mongolia Autonomous Region , Chui Lai ,

Ascentage Pharma Officially Included in Shenzhen-Hong Kong Stock Connect Program


Search jobs
Ascentage Pharma Officially Included in Shenzhen-Hong Kong Stock Connect Program
SUZHOU, China and ROCKVILLE, Md., Dec. 30, 2020 /PRNewswire/ Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the company was officially included into the Shenzhen-Hong Kong Stock Connect program (the Hong Kong Stock Connect ). This was officially announced by the Shenzhen Stock Exchange ( SZSE ) on December 25, 2020, which has been effective since December 28, 2020. This inclusion is the very first arrangement for the eligible pre-revenue biotech companies listed under Chapter 18A of Hong Kong s Main Board Listing Rules, and complied with the conditions for the inclusion in the Hong Kong Stock Connect. ....

Hong Kong , Western Australia , Dajun Yang , Ascentage Pharma , Seng Hong Kong , Prnewswire Ascentage Pharma , Shenzhen Stock Exchange , National Medical Products Administration , Drug Administration , Shenzhen Hong Kong Stock Connect , Kong Stock , Main Board Listing Rules , Hong Kong Stock , Hong Kong Stock Connect , Shenzhen Stock , Stock Connect , China Mainland , Mainland China , New Drug Application , Orphan Drug Designation , Hang Seng Composite Index , Hang Seng Hong Kong Listed Biotech Index , Hang Seng Healthcare Index , Hang Seng Index , Main Board , Stock Exchange ,